Abstract:Abstract The development of efficient aggregation‐induced emission (AIE) active probes is crucial for disease diagnosis, particularly for tumors and cardiovascular diseases. Current AIE‐active probes primarily focus on improving their water solubility to resist aggregation, thereby achieving an initial fluorescence‐off state. However, the complex biological environment can cause undesirable aggregation, resulting in false signals. To address this issue, we have ingeniously introduced an azo group into the AIE luminogen (AIEgen), developing a reductase‐activated AIE probe, Azo‐quinoline‐malononitrile (QM)‐PN, for imaging hypoxic environments. In this probe, the azo group promotes intramolecular motion through rapid E / Z isomerization, causing the excited state energy to dissipate via non‐radiative decay, thus turning off the initial fluorescence. In the presence of reductase, Azo‐QM‐PN is reduced and cleaved to produce the hydrophobic AIEgen NH 2 ‐QM‐PN, which subsequently aggregates and generates an in situ AIE signal, thereby imaging the hypoxic environment with reductase. Encapsulation of Azo‐QM‐PN with DSPE‐PEG 2000 results in the formation of the nanoprobe Azo‐QM‐PN NPs, which can effectively penetrate cell membranes, specifically illuminate tumor cells, monitor fluctuations in azo reductase levels, and deeply penetrate and image multicellular tumor spheroids, demonstrating potential for hypoxic tumor imaging. Additionally, the nanoprobe Azo‐QM‐PN NPs can selectively image hypoxic atherosclerotic plaque tissues, showing potential for detecting atherosclerosis. Therefore, in this study, we successfully developed an enzyme‐activated AIE probe for imaging hypoxic environments, laying the foundation for further clinical applications.

Hypoxia-Activated Fluorescent Probe Based on Self-Immolative Block Copolymer

AIEgen-Terminated Charge-Switchable Zwitterionic Azo Polymer for Tumor Hypoxia Imaging

Hypoxia-Responsive Molecular Probe Lighted up by Peptide Self-Assembly for Cancer Cell Imaging

Hypoxia-Triggered In Situ Self-Assembly Of A Charge Switchable Azo Polymer With Alegens For Tumor Imaging

An activatable azophenyl fluorescent probe for hypoxic fluorescence imaging in living cells

<i>In situ</i> construction of a self-assembled AIE probe for tumor hypoxia imaging

A water-soluble conjugated polymer with azobenzol side chains based on “turn-on” effect for hypoxic cell imaging

Novel Near‐Infrared Fluorescent Nanoprobe Synthesized by the RAFT‐Mediated PISA Strategy for Hypoxia‐Triggered Tumor Imaging and Azoreductase‐Responsive Drug Release

Polymer-based activatable optical probes for tumor fluorescence and photoacoustic imaging

"Turn-On" Activatable AIE Dots for Tumor Hypoxia Imaging.

Supramolecular fluorescence nanoprobe loaded with azobenzene for the detection of azoreductase: Selective light-up of hypoxic cells

A near-infrared multifunctional fluorescent probe for hypoxia monitoring and tumor-targeted therapy

Application of Azobenzene Derivative Probes in Hypoxia Cell Imaging

Hypoxia-activated probe for NIR fluorescence and photoacoustic dual-mode tumor imaging

A Turn-On Fluorescent Probe for Tumor Hypoxia Imaging in Living Cells

An azo substituted quinoline‐malononitrile enzyme‐activable aggregation‐induced emission nanoprobe for hypoxia imaging

Azo-based near-infrared fluorescent theranostic probe for tracking hypoxia-activated cancer chemotherapy in vivo.

Selective Turn-on Near-Infrared Fluorescence Probe for Hypoxic Tumor Cell Imaging

Fluorescent Probe for Hypoxia-triggered Imaging and Cancer Therapy

Self-Reporting Hypoxia-Responsive Supramolecular Phototheranostic Nanomaterials Based on AIEgen and Azocalixarene

Development of a Hypoxia-Activated Red-Emission Fluorescent Probe for in Vivo Tumor Microenvironment Imaging and Anti-Tumor Therapy